Logo
Conferences

Conferences

Catalog

Abstracts

Calendar

Official conference page for 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies .

About 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Audrey Kerby
79+
Email if you have questions

Faculty and committee

Conference program and agenda

Our Agenda

Day 1: Friday, October 24th, 2025

All timings are in Pacific Time (PDT, GMT-07:00) time.

09:00 AM - 10:00 AMRegistration, Breakfast & Exhibits
10:00 AM - 11:00 AMSession 1: Artificial Intelligence in Precision Oncology

Session Chair: Sylvia K. Plevritis, PhD

10:00 AM - 10:20 AM

Artificial Intelligence in Precision Oncology: Predicting Outcomes in Cancer – Haruka Itakura, MD, PhD

10:20 AM - 10:40 AM

Multi-modal AI for Cancer Biology and Clinical Decision Support – Sylvia K. Plevritis, PhD

10:40 AM - 11:00 AM

Panel Discussion – Haruka Itakura, MD, PhD; Sylvia K. Plevritis, PhD

11:00 AM - 12:00 PMSession 2: Oral Abstract Presentations

Session Chair: Marianne Dubard-Gault, MD

11:00 AM - 11:15 AM

Clinico-genomic Characterization of PALB2-Mutated Pancreatic Adenocarcinoma. – Jonathan Lee, MD

11:15 AM - 11:30 AM

Ph-like ALL Exhibits Unique Hematological Features with CD36 Overexpression: A Diagnostic and Prognostic Analysis of 1,021 Indian Patients. – Dikshat Gopal Gupta, PhD

11:30 AM - 11:45 AM

Race/ethnicity associated clinico-genomic, socioeconomic, and environmental predictors in metastatic non-small cell lung cancer (mNSCLC) treated with immunotherapy. – Nirosha Perera King, MD

11:45 AM - 12:00 PM

Utilization and Timing of First Tumor Next-generation Sequencing Testing (NGS) in Patients with Five Most Common Cancers in the USA. – Zeynep Irem Ozay, MD

12:00 PM - 01:00 PMLunch & Exhibits (Poster Presentation)
01:00 PM - 02:00 PMSession 3: Pathway-Based Targeted Therapies in Oncology

Session Chair: Pamela Munster, MD; Mark Daniel Pegram, MD

01:00 PM - 01:15 PM

RTK inhibitors in NSCLC – Nathaniel James Myall, MD

01:15 PM - 01:30 PM

PI3K Pathway – Pamela Munster, MD

01:30 PM - 01:45 PM

RAS/RAF in Melanoma – Adil Daud, MD

01:45 PM - 02:00 PM

Q & A/Discussion

02:00 PM - 03:20 PMSession 4: Molecular Tumor Board 1: Interesting and Challenging Cases in Precision Oncology

Session Chair: Mark Daniel Pegram, MD

02:00 PM - 02:20 PM

ESR1 Mutation – Milana v Dolezal, MD

02:20 PM - 02:40 PM

MTAP Deletion – Shruti Rajesh Patel, MD

02:40 PM - 03:00 PM

KRAS G12C Mutation – Surbhi Singhal, MD

03:00 PM - 03:20 PM

EZH2 Mutation in Sarcoma – Varun Monga, MD, MBBS

03:20 PM - 03:30 PMBreak & Exhibits
03:30 PM - 04:00 PMSession 5: Liquid Biopsy and Non-Invasive Testing

Session Chair: Mamta Parikh, MD

03:30 PM - 04:00 PM

Panel Discussion – Nicholas Mitsiades, MD; Jason N Rosenbaum, MD; Ibrahim Halil Sahin, MD

04:00 PM - 04:45 PMSession 6: Roundtable Discussion: Ethical Challenges in Precision Oncology

Session Chair: Henry T Greely, JD

04:00 PM - 04:15 PM

Ethics in Precision Oncology – Henry T Greely, JD

04:15 PM - 04:45 PM

Panel Discussion – Sachdev P Thomas, MD; Meera Ragavan, MD; Alborz Alali, MD

04:45 PM - 05:30 PMSession 7: Personalized Cancer Vaccines in Immuno-Oncology

Session Chair: Pamela Munster, MD

04:45 PM - 05:05 PM

Development of Personalized Cancer Vaccines and Immunotherapy – Chen Fu, MD

05:05 PM - 05:30 PM

Panel Discussion – Adil Daud, MD; Chen Fu, MD

05:30 PM - 06:30 PMNetworking Reception Sponsored by Natera

Day 2: Saturday, October 25th, 2025

07:00 AM - 08:30 AMRegistration, Breakfast, and Exhibits

Venue and map

Accreditations and continuing education

Acknowledgement of Commercial Support

This activity is supported with Independent Medical Education grants from Novartis, Merck, and Gilead.

Accreditation

Registration and pricing

Exhibitors and sponsorship